Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Cholidou (Athens, Greece), N. Anagnostopoulos (Athens, Greece), D. Grapsa (Athens, Greece), I. Gkiozos (Athens, Greece), E. Kokkotou (Athens, Greece), A. Vassias (Athens, Greece), S. Tsagouli (Athens, Greece), P. Bakakos (Athens, Greece), I. Kotteas (Athens, Greece), A. Charpidou (Athens, Greece). Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study. 3037

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Prognostic parameters in non-small cell lung cancer (211 cases) Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Prognostic value of apoptotic index in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Prognostic value of smoking status in operated non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Prognostic factors for non-small cell lung cancer: an analysis of last decade Source: Eur Respir J 2005; 26: Suppl. 49, 325s Year: 2005 Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008 Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011 Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001 Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019 Year: 2019 A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Tumour metabolic-flow difference as a potential predictor of survival in non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data Source: Eur Respir J 2015; 46: 1751-1761 Year: 2015 Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC) Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors Year: 2008 PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011